-
1
-
-
79954622209
-
Therapeutic in vivo gene transfer for genetic disease using AAV: progress and challenges
-
Mingozzi F., High K.A. Therapeutic in vivo gene transfer for genetic disease using AAV: progress and challenges. Nat. Rev. Genet. 2011, 12(5):341-355.
-
(2011)
Nat. Rev. Genet.
, vol.12
, Issue.5
, pp. 341-355
-
-
Mingozzi, F.1
High, K.A.2
-
2
-
-
44349170706
-
Analysis of AAV serotypes 1-9 mediated gene expression and tropism in mice after systemic injection
-
Zincarelli C., Soltys S., Rengo G., Rabinowitz J.E. Analysis of AAV serotypes 1-9 mediated gene expression and tropism in mice after systemic injection. Mol. Ther. 2008, 16(6):1073-1080.
-
(2008)
Mol. Ther.
, vol.16
, Issue.6
, pp. 1073-1080
-
-
Zincarelli, C.1
Soltys, S.2
Rengo, G.3
Rabinowitz, J.E.4
-
3
-
-
84884691211
-
Analysis of transduction efficiency, tropism and axonal transport of AAV serotypes 1, 2, 5, 6, 8 and 9 in the mouse brain
-
Aschauer D.F., Kreuz S., Rumpel S. Analysis of transduction efficiency, tropism and axonal transport of AAV serotypes 1, 2, 5, 6, 8 and 9 in the mouse brain. PLoS ONE 2013, 8(9):e76310.
-
(2013)
PLoS ONE
, vol.8
, Issue.9
-
-
Aschauer, D.F.1
Kreuz, S.2
Rumpel, S.3
-
4
-
-
4344566457
-
Recombinant AAV viral vectors pseudotyped with viral capsids from serotypes 1, 2, and 5 display differential efficiency and cell tropism after delivery to different regions of the central nervous system
-
Burger C., Gorbatyuk O.S., Velardo M.J., Peden C.S., Williams P., Zolotukhin S., Reier P.J., Mandel R.J., Muzyczka N. Recombinant AAV viral vectors pseudotyped with viral capsids from serotypes 1, 2, and 5 display differential efficiency and cell tropism after delivery to different regions of the central nervous system. Mol. Ther. 2004, 10(2):302-317.
-
(2004)
Mol. Ther.
, vol.10
, Issue.2
, pp. 302-317
-
-
Burger, C.1
Gorbatyuk, O.S.2
Velardo, M.J.3
Peden, C.S.4
Williams, P.5
Zolotukhin, S.6
Reier, P.J.7
Mandel, R.J.8
Muzyczka, N.9
-
5
-
-
79958191163
-
Adeno-associated virus (AAV) vectors in the CNS
-
McCown T.J. Adeno-associated virus (AAV) vectors in the CNS. Curr. Gene Ther. 2011, 11(3):181-188.
-
(2011)
Curr. Gene Ther.
, vol.11
, Issue.3
, pp. 181-188
-
-
McCown, T.J.1
-
6
-
-
84879086501
-
Safety/feasibility of targeting the substantia nigra with AAV2-neurturin in Parkinson patients
-
Bartus R.T., Baumann T.L., Siffert J., Herzog C.D., Alterman R., Boulis N., Turner D.A., Stacy M., Lang A.E., Lozano A.M., Olanow C.W. Safety/feasibility of targeting the substantia nigra with AAV2-neurturin in Parkinson patients. Neurology 2013, 80(18):1698-1701.
-
(2013)
Neurology
, vol.80
, Issue.18
, pp. 1698-1701
-
-
Bartus, R.T.1
Baumann, T.L.2
Siffert, J.3
Herzog, C.D.4
Alterman, R.5
Boulis, N.6
Turner, D.A.7
Stacy, M.8
Lang, A.E.9
Lozano, A.M.10
Olanow, C.W.11
-
7
-
-
84860130544
-
Long-term evaluation of a phase 1 study of AADC gene therapy for Parkinson's disease
-
Mittermeyer G., Christine C.W., Rosenbluth K.H., Baker S.L., Starr P., Larson P., Kaplan P.L., Forsayeth J., Aminoff M.J., Bankiewicz K.S. Long-term evaluation of a phase 1 study of AADC gene therapy for Parkinson's disease. Hum. Gene Ther. 2012, 23(4):377-381.
-
(2012)
Hum. Gene Ther.
, vol.23
, Issue.4
, pp. 377-381
-
-
Mittermeyer, G.1
Christine, C.W.2
Rosenbluth, K.H.3
Baker, S.L.4
Starr, P.5
Larson, P.6
Kaplan, P.L.7
Forsayeth, J.8
Aminoff, M.J.9
Bankiewicz, K.S.10
-
8
-
-
85027921807
-
A phase1 study of stereotactic gene delivery of AAV2-NGF for Alzheimer's disease
-
Rafii M.S., Baumann T.L., Bakay R.A., Ostrove J.M., Siffert J., Fleisher A.S., Herzog C.D., Barba D., Pay M., Salmon D.P., Chu Y., Kordower J.H., Bishop K., Keator D., Potkin S., Bartus R.T. A phase1 study of stereotactic gene delivery of AAV2-NGF for Alzheimer's disease. Alzheimers Dement. 2014.
-
(2014)
Alzheimers Dement.
-
-
Rafii, M.S.1
Baumann, T.L.2
Bakay, R.A.3
Ostrove, J.M.4
Siffert, J.5
Fleisher, A.S.6
Herzog, C.D.7
Barba, D.8
Pay, M.9
Salmon, D.P.10
Chu, Y.11
Kordower, J.H.12
Bishop, K.13
Keator, D.14
Potkin, S.15
Bartus, R.T.16
-
9
-
-
79961032418
-
Several rAAV vectors efficiently cross the blood-brain barrier and transduce neurons and astrocytes in the neonatal mouse central nervous system
-
Zhang H., Yang B., Mu X., Ahmed S.S., Su Q., He R., Wang H., Mueller C., Sena-Esteves M., Brown R., Xu Z., Gao G. Several rAAV vectors efficiently cross the blood-brain barrier and transduce neurons and astrocytes in the neonatal mouse central nervous system. Mol. Ther. 2011, 19(8):1440-1448.
-
(2011)
Mol. Ther.
, vol.19
, Issue.8
, pp. 1440-1448
-
-
Zhang, H.1
Yang, B.2
Mu, X.3
Ahmed, S.S.4
Su, Q.5
He, R.6
Wang, H.7
Mueller, C.8
Sena-Esteves, M.9
Brown, R.10
Xu, Z.11
Gao, G.12
-
10
-
-
67649861393
-
Intravenous administration of self-complementary AAV9 enables transgene delivery to adult motor neurons
-
Duque S., Joussemet B., Riviere C., Marais T., Dubreil L., Douar A.M., Fyfe J., Moullier P., Colle M.A., Barkats M. Intravenous administration of self-complementary AAV9 enables transgene delivery to adult motor neurons. Mol. Ther. 2009, 17(7):1187-1196.
-
(2009)
Mol. Ther.
, vol.17
, Issue.7
, pp. 1187-1196
-
-
Duque, S.1
Joussemet, B.2
Riviere, C.3
Marais, T.4
Dubreil, L.5
Douar, A.M.6
Fyfe, J.7
Moullier, P.8
Colle, M.A.9
Barkats, M.10
-
11
-
-
60149106907
-
Intravascular AAV9 preferentially targets neonatal neurons and adult astrocytes
-
Foust K.D., Nurre E., Montgomery C.L., Hernandez A., Chan C.M., Kaspar B.K. Intravascular AAV9 preferentially targets neonatal neurons and adult astrocytes. Nat. Biotechnol. 2009, 27(1):59-65.
-
(2009)
Nat. Biotechnol.
, vol.27
, Issue.1
, pp. 59-65
-
-
Foust, K.D.1
Nurre, E.2
Montgomery, C.L.3
Hernandez, A.4
Chan, C.M.5
Kaspar, B.K.6
-
12
-
-
84879984498
-
Fetal brain-directed AAV gene therapy results in rapid, robust, and persistent transduction of mouse choroid plexus epithelia
-
Haddad M.R., Donsante A., Zerfas P., Kaler S.G. Fetal brain-directed AAV gene therapy results in rapid, robust, and persistent transduction of mouse choroid plexus epithelia. Mol. Ther. Nucleic Acids 2013, 2:e101.
-
(2013)
Mol. Ther. Nucleic Acids
, vol.2
-
-
Haddad, M.R.1
Donsante, A.2
Zerfas, P.3
Kaler, S.G.4
-
13
-
-
84879371255
-
Capsid serotype and timing of injection determines AAV transduction in the neonatal mice brain
-
Chakrabarty P., Rosario A., Cruz P., Siemienski Z., Ceballos-Diaz C., Crosby K., Jansen K., Borchelt D.R., Kim J.Y., Jankowsky J.L., Golde T.E., Levites Y. Capsid serotype and timing of injection determines AAV transduction in the neonatal mice brain. PLoS ONE 2013, 8(6):e67680.
-
(2013)
PLoS ONE
, vol.8
, Issue.6
-
-
Chakrabarty, P.1
Rosario, A.2
Cruz, P.3
Siemienski, Z.4
Ceballos-Diaz, C.5
Crosby, K.6
Jansen, K.7
Borchelt, D.R.8
Kim, J.Y.9
Jankowsky, J.L.10
Golde, T.E.11
Levites, Y.12
-
14
-
-
84861326894
-
The advent of AAV9 expands applications for brain and spinal cord gene delivery
-
Dayton R.D., Wang D.B., Klein R.L. The advent of AAV9 expands applications for brain and spinal cord gene delivery. Expert Opin. Biol. Ther. 2012, 12(6):757-766.
-
(2012)
Expert Opin. Biol. Ther.
, vol.12
, Issue.6
, pp. 757-766
-
-
Dayton, R.D.1
Wang, D.B.2
Klein, R.L.3
-
15
-
-
61649101243
-
AAV9: a potential blood-brain barrier buster
-
Manfredsson F.P., Rising A.C., Mandel R.J. AAV9: a potential blood-brain barrier buster. Mol. Ther. 2009, 17(3):403-405.
-
(2009)
Mol. Ther.
, vol.17
, Issue.3
, pp. 403-405
-
-
Manfredsson, F.P.1
Rising, A.C.2
Mandel, R.J.3
-
16
-
-
84890119907
-
Therapeutic AAV9-mediated suppression of mutant SOD1 slows disease progression and extends survival in models of inherited ALS
-
Foust K.D., Salazar D.L., Likhite S., Ferraiuolo L., Ditsworth D., Ilieva H., Meyer K., Schmelzer L., Braun L., Cleveland D.W., Kaspar B.K. Therapeutic AAV9-mediated suppression of mutant SOD1 slows disease progression and extends survival in models of inherited ALS. Mol. Ther. 2013, 21(12):2148-2159.
-
(2013)
Mol. Ther.
, vol.21
, Issue.12
, pp. 2148-2159
-
-
Foust, K.D.1
Salazar, D.L.2
Likhite, S.3
Ferraiuolo, L.4
Ditsworth, D.5
Ilieva, H.6
Meyer, K.7
Schmelzer, L.8
Braun, L.9
Cleveland, D.W.10
Kaspar, B.K.11
-
17
-
-
78751700314
-
Intravenous scAAV9 delivery of a codon-optimized SMN1 sequence rescues SMA mice
-
Dominguez E., Marais T., Chatauret N., Benkhelifa-Ziyyat S., Duque S., Ravassard P., Carcenac R., Astord S., Pereira de Moura A., Voit T., Barkats M. Intravenous scAAV9 delivery of a codon-optimized SMN1 sequence rescues SMA mice. Hum. Mol. Genet. 2011, 20(4):681-693.
-
(2011)
Hum. Mol. Genet.
, vol.20
, Issue.4
, pp. 681-693
-
-
Dominguez, E.1
Marais, T.2
Chatauret, N.3
Benkhelifa-Ziyyat, S.4
Duque, S.5
Ravassard, P.6
Carcenac, R.7
Astord, S.8
Pereira de Moura, A.9
Voit, T.10
Barkats, M.11
-
18
-
-
77749249680
-
Rescue of the spinal muscular atrophy phenotype in a mouse model by early postnatal delivery of SMN
-
Foust K.D., Wang X., McGovern V.L., Braun L., Bevan A.K., Haidet A.M., Le T.T., Morales P.R., Rich M.M., Burghes A.H., Kaspar B.K. Rescue of the spinal muscular atrophy phenotype in a mouse model by early postnatal delivery of SMN. Nat. Biotechnol. 2010, 28(3):271-274.
-
(2010)
Nat. Biotechnol.
, vol.28
, Issue.3
, pp. 271-274
-
-
Foust, K.D.1
Wang, X.2
McGovern, V.L.3
Braun, L.4
Bevan, A.K.5
Haidet, A.M.6
Le, T.T.7
Morales, P.R.8
Rich, M.M.9
Burghes, A.H.10
Kaspar, B.K.11
-
19
-
-
84858026947
-
Decreasing disease severity in symptomatic, Smn(-/-);SMN2(+/+), spinal muscular atrophy mice following scAAV9-SMN delivery
-
Glascock J.J., Osman E.Y., Wetz M.J., Krogman M.M., Shababi M., Lorson C.L. Decreasing disease severity in symptomatic, Smn(-/-);SMN2(+/+), spinal muscular atrophy mice following scAAV9-SMN delivery. Hum. Gene Ther. 2012, 23(3):330-335.
-
(2012)
Hum. Gene Ther.
, vol.23
, Issue.3
, pp. 330-335
-
-
Glascock, J.J.1
Osman, E.Y.2
Wetz, M.J.3
Krogman, M.M.4
Shababi, M.5
Lorson, C.L.6
-
20
-
-
84855760635
-
Direct central nervous system delivery provides enhanced protection following vector mediated gene replacement in a severe model of spinal muscular atrophy
-
Glascock J.J., Shababi M., Wetz M.J., Krogman M.M., Lorson C.L. Direct central nervous system delivery provides enhanced protection following vector mediated gene replacement in a severe model of spinal muscular atrophy. Biochem. Biophys. Res. Commun. 2012, 417(1):376-381.
-
(2012)
Biochem. Biophys. Res. Commun.
, vol.417
, Issue.1
, pp. 376-381
-
-
Glascock, J.J.1
Shababi, M.2
Wetz, M.J.3
Krogman, M.M.4
Lorson, C.L.5
-
22
-
-
77955602597
-
Systemic delivery of scAAV9 expressing SMN prolongs survival in a model of spinal muscular atrophy
-
Valori C.F., Ning K., Wyles M., Mead R.J., Grierson A.J., Shaw P.J., Azzouz M. Systemic delivery of scAAV9 expressing SMN prolongs survival in a model of spinal muscular atrophy. Sci. Transl. Med. 2010, 2(35):35ra42.
-
(2010)
Sci. Transl. Med.
, vol.2
, Issue.35
-
-
Valori, C.F.1
Ning, K.2
Wyles, M.3
Mead, R.J.4
Grierson, A.J.5
Shaw, P.J.6
Azzouz, M.7
-
23
-
-
74049164709
-
Non-cell autonomous toxicity in neurodegenerative disorders: ALS and beyond
-
Ilieva H., Polymenidou M., Cleveland D.W. Non-cell autonomous toxicity in neurodegenerative disorders: ALS and beyond. J. Cell Biol. 2009, 187(6):761-772.
-
(2009)
J. Cell Biol.
, vol.187
, Issue.6
, pp. 761-772
-
-
Ilieva, H.1
Polymenidou, M.2
Cleveland, D.W.3
-
24
-
-
80052314526
-
Manufacturing of adeno-associated viruses, for example: AAV2
-
Chen H. Manufacturing of adeno-associated viruses, for example: AAV2. Methods Mol. Biol. 2011, 737:235-246.
-
(2011)
Methods Mol. Biol.
, vol.737
, pp. 235-246
-
-
Chen, H.1
-
25
-
-
80054879102
-
Delivery of therapeutic agents through intracerebroventricular (ICV) and intravenous (IV) injection in mice
-
Glascock J.J., Osman E.Y., Coady T.H., Rose F.F., Shababi M., Lorson C.L. Delivery of therapeutic agents through intracerebroventricular (ICV) and intravenous (IV) injection in mice. J. Vis. Exp. 2011, (56).
-
(2011)
J. Vis. Exp.
, Issue.56
-
-
Glascock, J.J.1
Osman, E.Y.2
Coady, T.H.3
Rose, F.F.4
Shababi, M.5
Lorson, C.L.6
-
26
-
-
0035203152
-
Widespread gene delivery and structure-specific patterns of expression in the brain after intraventricular injections of neonatal mice with an adeno-associated virus vector
-
Passini M.A., Wolfe J.H. Widespread gene delivery and structure-specific patterns of expression in the brain after intraventricular injections of neonatal mice with an adeno-associated virus vector. J. Virol. 2001, 75(24):12382-12392.
-
(2001)
J. Virol.
, vol.75
, Issue.24
, pp. 12382-12392
-
-
Passini, M.A.1
Wolfe, J.H.2
-
27
-
-
0004036940
-
-
Elsevier, Amsterdam
-
Hof P.R., Young W.G., Bloom F.E., Belichenko P.V., Celio M.R. Comparative Cytoarchitectonic Atlas of the C57BL/6 and 129/Sv Mouse Brains 2000, Elsevier, Amsterdam.
-
(2000)
Comparative Cytoarchitectonic Atlas of the C57BL/6 and 129/Sv Mouse Brains
-
-
Hof, P.R.1
Young, W.G.2
Bloom, F.E.3
Belichenko, P.V.4
Celio, M.R.5
-
28
-
-
63849332293
-
Dynamic changes in presynaptic and axonal transport proteins combined with striatal neuroinflammation precede dopaminergic neuronal loss in a rat model of AAV alpha-synucleinopathy
-
Chung C.Y., Koprich J.B., Siddiqi H., Isacson O. Dynamic changes in presynaptic and axonal transport proteins combined with striatal neuroinflammation precede dopaminergic neuronal loss in a rat model of AAV alpha-synucleinopathy. J. Neurosci. 2009, 29(11):3365-3373.
-
(2009)
J. Neurosci.
, vol.29
, Issue.11
, pp. 3365-3373
-
-
Chung, C.Y.1
Koprich, J.B.2
Siddiqi, H.3
Isacson, O.4
-
29
-
-
54749126318
-
Expanded repertoire of AAV vector serotypes mediate unique patterns of transduction in mouse brain
-
Cearley C.N., Vandenberghe L.H., Parente M.K., Carnish E.R., Wilson J.M., Wolfe J.H. Expanded repertoire of AAV vector serotypes mediate unique patterns of transduction in mouse brain. Mol. Ther. 2008, 16(10):1710-1718.
-
(2008)
Mol. Ther.
, vol.16
, Issue.10
, pp. 1710-1718
-
-
Cearley, C.N.1
Vandenberghe, L.H.2
Parente, M.K.3
Carnish, E.R.4
Wilson, J.M.5
Wolfe, J.H.6
-
30
-
-
37549061385
-
AAV8, 9, Rh10, Rh43 vector gene transfer in the rat brain: effects of serotype, promoter and purification method
-
Klein R.L., Dayton R.D., Tatom J.B., Henderson K.M., Henning P.P. AAV8, 9, Rh10, Rh43 vector gene transfer in the rat brain: effects of serotype, promoter and purification method. Mol. Ther. 2008, 16(1):89-96.
-
(2008)
Mol. Ther.
, vol.16
, Issue.1
, pp. 89-96
-
-
Klein, R.L.1
Dayton, R.D.2
Tatom, J.B.3
Henderson, K.M.4
Henning, P.P.5
-
31
-
-
3042786281
-
Promoters and control elements: designing expression cassettes for gene therapy
-
Papadakis E.D., Nicklin S.A., Baker A.H., White S.J. Promoters and control elements: designing expression cassettes for gene therapy. Curr. Gene Ther. 2004, 4(1):89-113.
-
(2004)
Curr. Gene Ther.
, vol.4
, Issue.1
, pp. 89-113
-
-
Papadakis, E.D.1
Nicklin, S.A.2
Baker, A.H.3
White, S.J.4
-
32
-
-
1042282178
-
Long-term transgene expression can be mediated in the brain by adenoviral vectors when powerful neuron-specific promoters are used
-
Glover C.P., Bienemann A.S., Hopton M., Harding T.C., Kew J.N., Uney J.B. Long-term transgene expression can be mediated in the brain by adenoviral vectors when powerful neuron-specific promoters are used. J. Gene Med. 2003, 5(7):554-559.
-
(2003)
J. Gene Med.
, vol.5
, Issue.7
, pp. 554-559
-
-
Glover, C.P.1
Bienemann, A.S.2
Hopton, M.3
Harding, T.C.4
Kew, J.N.5
Uney, J.B.6
-
33
-
-
0037297303
-
Human synapsin 1 gene promoter confers highly neuron-specific long-term transgene expression from an adenoviral vector in the adult rat brain depending on the transduced area
-
Kugler S., Kilic E., Bahr M. Human synapsin 1 gene promoter confers highly neuron-specific long-term transgene expression from an adenoviral vector in the adult rat brain depending on the transduced area. Gene Ther. 2003, 10(4):337-347.
-
(2003)
Gene Ther.
, vol.10
, Issue.4
, pp. 337-347
-
-
Kugler, S.1
Kilic, E.2
Bahr, M.3
-
34
-
-
84893586080
-
Intracerebroventricular Injection of adeno-associated virus 6 and 9 vectors for cell type-specific transgene expression in the spinal cord
-
Dirren E., Towne C.L., Setola V., Redmond D.E., Schneider B.L., Aebischer P. Intracerebroventricular Injection of adeno-associated virus 6 and 9 vectors for cell type-specific transgene expression in the spinal cord. Hum. Gene Ther. 2014.
-
(2014)
Hum. Gene Ther.
-
-
Dirren, E.1
Towne, C.L.2
Setola, V.3
Redmond, D.E.4
Schneider, B.L.5
Aebischer, P.6
-
35
-
-
84879687753
-
Selective forelimb impairment in rats expressing a pathological TDP-43 25kDa C-terminal fragment to mimic amyotrophic lateral sclerosis
-
Dayton R.D., Gitcho M.A., Orchard E.A., Wilson J.D., Wang D.B., Cain C.D., Johnson J.A., Zhang Y.J., Petrucelli L., Mathis J.M., Klein R.L. Selective forelimb impairment in rats expressing a pathological TDP-43 25kDa C-terminal fragment to mimic amyotrophic lateral sclerosis. Mol. Ther. 2013, 21(7):1324-1334.
-
(2013)
Mol. Ther.
, vol.21
, Issue.7
, pp. 1324-1334
-
-
Dayton, R.D.1
Gitcho, M.A.2
Orchard, E.A.3
Wilson, J.D.4
Wang, D.B.5
Cain, C.D.6
Johnson, J.A.7
Zhang, Y.J.8
Petrucelli, L.9
Mathis, J.M.10
Klein, R.L.11
-
36
-
-
78650903887
-
Expansive gene transfer in the rat CNS rapidly produces amyotrophic lateral sclerosis relevant sequelae when TDP-43 is overexpressed
-
Wang D.B., Dayton R.D., Henning P.P., Cain C.D., Zhao L.R., Schrott L.M., Orchard E.A., Knight D.S., Klein R.L. Expansive gene transfer in the rat CNS rapidly produces amyotrophic lateral sclerosis relevant sequelae when TDP-43 is overexpressed. Mol. Ther. 2010, 18(12):2064-2074.
-
(2010)
Mol. Ther.
, vol.18
, Issue.12
, pp. 2064-2074
-
-
Wang, D.B.1
Dayton, R.D.2
Henning, P.P.3
Cain, C.D.4
Zhao, L.R.5
Schrott, L.M.6
Orchard, E.A.7
Knight, D.S.8
Klein, R.L.9
-
37
-
-
33751111439
-
Intracranial adeno-associated virus-mediated delivery of anti-pan amyloid beta, amyloid beta40, and amyloid beta42 single-chain variable fragments attenuates plaque pathology in amyloid precursor protein mice
-
Levites Y., Jansen K., Smithson L.A., Dakin R., Holloway V.M., Das P., Golde T.E. Intracranial adeno-associated virus-mediated delivery of anti-pan amyloid beta, amyloid beta40, and amyloid beta42 single-chain variable fragments attenuates plaque pathology in amyloid precursor protein mice. J. Neurosci. 2006, 26(46):11923-11928.
-
(2006)
J. Neurosci.
, vol.26
, Issue.46
, pp. 11923-11928
-
-
Levites, Y.1
Jansen, K.2
Smithson, L.A.3
Dakin, R.4
Holloway, V.M.5
Das, P.6
Golde, T.E.7
|